Vasopressin investigated as potential rescue therapy in critically ill children

Vasopressin, a synthesized peptide hormone, is emerging as a potentially major advancement in the management of critically ill children. If future and ongoing clinical trials support its efficacy and safety in the pediatric population, vasopressin could be used as rescue therapy in children with refractory shock and cardiac arrest, with close monitoring advised for adverse effects, according to a recent review in Indian Pediatrics.

Although vasopressin is not currently considered a standard of care for vasodilatory shock states and cardiac arrest, it has both...

Log in or register for free to continue reading
Register Now For Free Already Registered? Log In
This entry was posted in Pediatrics, Pharmacotherapy, Primary Care and tagged , , , , , , , , , , , , , . Volume: .

Post a Comment

You must be logged in to post a comment.